Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC) - Aix-Marseille Université Access content directly
Journal Articles Journal of Thoracic Oncology Year : 2019

Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC)

Domains

Cancer
Fichier principal
Vignette du fichier
S1556086419300401.pdf (668.74 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-02104417 , version 1 (25-10-2021)

Licence

Attribution - NonCommercial

Identifiers

Cite

Arnaud Jeanson, Pascale Tomasini, Maxime Souquet-Bressand, Nicolas Brandone, Mohamed Boucekine, et al.. Efficacy of Immune Checkpoint Inhibitors in KRAS-Mutant Non-Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology, 2019, 14 (6), pp.1095-1101. ⟨10.1016/j.jtho.2019.01.011⟩. ⟨hal-02104417⟩
201 View
246 Download

Altmetric

Share

Gmail Facebook X LinkedIn More